This Day On The Street
Continue to site
ADVERTISEMENT
This account is pending registration confirmation. Please click on the link within the confirmation email previously sent you to complete registration.
Need a new registration confirmation email? Click here

Epigenetic Therapies And Technologies: World Market Prospects 2013-2023

Ordering now lets you discover commercial prospects to 2023 for epigenetics

Visiongain's study is for everyone needing forward-looking analysis of pharmaceutical and diagnostic biotechnology. You find data, trends and predictions. Please ask for our report now.

Visiongain is a trading partner with the US Federal Government

CCR Ref number: KD4R6

Table of Contents 1. Executive Summary

1.1 Epigenetic Therapies and Technologies: World Market Review1.2 Report Contents1.3 Research and Analysis Methods

2. An Introduction to Epigenetics

2.1 How is Epigenetics Defined?

2.1.1 Epigenetic Mechanisms

2.1.2 A Brief History of Epigenetic Research

2.2 The Links between Epigenetics and Disease

2.2.1 The Role of Lifestyle in Epigenetics

2.2.2 Epigenetics and Cancer

2.2.3 Epigenetics in Inherited Disorders

2.2.4 Epigenetics in Neurological Diseases

2.3 Epigenetics for Disease Diagnosis

2.3.1 Diagnosing for Breast Cancer

2.3.2 Colorectal Cancer: The Importance of Early Diagnosis

2.3.3 Diagnostics for Lung Cancer: Difficulty in Accessing Samples

2.3.4 Diagnostics for Prostate Cancer

2.4 The Use of Epigenetics in Treating Disease

2.4.1 DNA Methyltransferase (DNMT) Inhibitors

2.4.1.1 Myelodysplastic Syndromes (MDS)

2.4.2 Histone Deacetylase (HDAC) Inhibitors

2.4.2.1 Cutaneous T Cell Lymphoma (CTCL)

2.4.2.2 Peripheral T Cell Lymphoma (PTCL)

2.5 Drug Discovery and Development Tools Using Epigenetics

2.5.1 Bisulphite Screening for DNA Methylation

2.5.2 Chromatin Immunoprecipitation (ChIP) for Histone Modification

3. The Epigenetic Therapies and Technologies Market 2013-2023

3.1 The Epigenetic Therapies and Technologies Market 2011-20123.1.1 Leading Sectors of the Market 2011-20123.2 The Epigenetic Therapies and Technologies Market 2013-20233.2.1 The Epigenetic Therapies and Technologies Market: Overall Revenue Forecast 2013-20233.2.2 What Will Drive Revenue Growth for Epigenetic Therapies and Technologies?3.2.3 Rising Importance for Diagnostics Revenue 2013-20233.3 Epigenetic Therapies Submarket 2013-20233.3.1 Epigenetic Therapies Submarket: Revenue Forecast 2013-20233.3.2 Factors Influencing Epigenetic Therapy Uptake and Revenues 2013-20233.4 Epigenetic Technologies Submarket 2013-20233.4.1 Epigenetic Technologies Submarket: Revenue Forecast 2013-20233.4.2 Epigenetic Technologies Submarket: Drivers and Restraints 2013-20233.5 Epigenetic Diagnostics Submarket 2013-20233.5.1 Epigenetic Diagnostics Submarket: Revenue Forecast 2013-20233.5.2 New Product Launches to Drive Growth 2013-2023

4 of 12

Check Out Our Best Services for Investors

Action Alerts PLUS

Portfolio Manager Jim Cramer and Director of Research Jack Mohr reveal their investment tactics while giving advanced notice before every trade.

Product Features:
  • $2.5+ million portfolio
  • Large-cap and dividend focus
  • Intraday trade alerts from Cramer
Quant Ratings

Access the tool that DOMINATES the Russell 2000 and the S&P 500.

Product Features:
  • Buy, hold, or sell recommendations for over 4,300 stocks
  • Unlimited research reports on your favorite stocks
  • A custom stock screener
Stocks Under $10

David Peltier uncovers low dollar stocks with serious upside potential that are flying under Wall Street's radar.

Product Features:
  • Model portfolio
  • Stocks trading below $10
  • Intraday trade alerts
14-Days Free
Only $9.95
14-Days Free
Submit an article to us!
SYM TRADE IT LAST %CHG

Markets

DOW 18,070.40 +46.34 0.26%
S&P 500 2,114.49 +6.20 0.29%
NASDAQ 5,016.9290 +11.5380 0.23%

Partners Compare Online Brokers

Free Reports

Top Rated Stocks Top Rated Funds Top Rated ETFs